Polymyositis Clinical Trial
Official title:
Exploration of the Diagnostic Capabilities of Ultrasound of the Oropharynx and Larynx
This study will assess the use of ultrasound-a test that uses sound waves to produce
images-as a diagnostic tool for evaluating speech and swallowing.
The following categories of individuals may be eligible for this study: 1) healthy
volunteers between 20 and 85 years old with normal speech and hearing, 2) patients 6 to 85
years old with developmental neurological deficits in speech or swallowing, and 3) patients
with tumors of the oral cavity, pharynx or larynx being treated at the Greater Baltimore
Medical Center.
Participants will undergo a 30-minute speech and oral motion evaluation, in which they
imitate sounds, words and oral movements while a speech pathologist evaluates their lip,
tongue and palate movements. They may also be asked to drink a small amount of water for
examination of swallowing function.
For the ultrasound examination, a 3/4-inch transducer (device for transmitting and receiving
sound waves) is placed under the participant's chin. While the transducer is in place, the
subject 1) repeats sounds and a series of syllables in several sequences, 2) swallows three
times with and without a small amount of water, and 3) swallows 3 teaspoons of non-fat
pudding. The ultrasound images are recorded on tape for later analysis.
Status | Completed |
Enrollment | 570 |
Est. completion date | November 2004 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | N/A and older |
Eligibility |
INCLUSION CRITERIA: Normal volunteers: Normal volunteers ages 21 to 85 may be asked to participate in a study of speech and swallowing utilizing a traditional clinical examination of oral-motor performance. If the subjects are without deficits in dental occlusion, speech articulation, tongue and lip strength, tongue and lip mobility, palatal function and oral sensation they will be asked to participate in an ultrasonic evaluation of tongue/hyoid interaction during swallowing and speech. Children will be included if they are referred with a medical condition that affects the oral pharyngeal phase of swallowing, voice production or laryngeal function and the investigator needs to evaluate functional performance and safety for oral feeding. Neurological Group: Subjects aged 6 to 85 with diagnosed developmental, neuromotor, systemic, genetic, neurologic, structural and post surgical dysfunction who have deficits in speech (dysarthria) and/or swallow (dysphagia) may be asked to participate in this study of ultrasonic imaging. Aging patients with and without dementia may also be studied. Patients with Post Polio Syndrome, Polymyositis, Dermatomyositis, Toricollis, Cerebellar Degeneration, Parkinson's disease, Progressive Supranuclear Palsy, ALS, Cystinosis, are among the conditions of interest. Subjects with complaints of oral dryness, and patients who have undergone mandibular and oral surgery may also be studied during swallowing. Oropharyngeal/Laryngeal Tumors: Patients will be seen who are enrolled in NCI and NIDCD protocols for head and neck tumors. EXCLUSION CRITERIA Normal Subjects: Hearing impairment reported (above 40 db, bilaterally) Dentures Oral Prosthesis Palatal surgery or other restorative dental surgery Radial neck dissection, glossectomy Tumor or masses in neck or tongue Cerebral vascular attack Stuttering Non-English speaker Childhood articulation impairment |
N/A
Country | Name | City | State |
---|---|---|---|
United States | Warren G. Magnuson Clinical Center (CC) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institutes of Health Clinical Center (CC) |
United States,
Shawker TH, Sonies B, Hall TE, Baum BF. Ultrasound analysis of tongue, hyoid, and larynx activity during swallowing. Invest Radiol. 1984 Mar-Apr;19(2):82-6. — View Citation
Sonies BC, Dalakas MC. Dysphagia in patients with the post-polio syndrome. N Engl J Med. 1991 Apr 25;324(17):1162-7. — View Citation
Sonies BC, Ekman EF, Andersson HC, Adamson MD, Kaler SG, Markello TC, Gahl WA. Swallowing dysfunction in nephropathic cystinosis. N Engl J Med. 1990 Aug 30;323(9):565-70. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05833711 -
Study Evaluating Efficacy and Safety of Froniglutide (PF1801) in Patients With Idiopathic Inflammatory Myopathy
|
Phase 2 | |
Completed |
NCT01906372 -
Acthar in Treatment of Refractory Dermatomyositis and Polymyositis
|
Phase 2 | |
Completed |
NCT01813617 -
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
Completed |
NCT01165008 -
Anakinra in Myositis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05832034 -
Add-on Intravenous Immunoglobulins in Early Myositis
|
Phase 2 | |
Recruiting |
NCT05979441 -
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
Not yet recruiting |
NCT05027152 -
Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties
|
N/A | |
Active, not recruiting |
NCT04723303 -
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
|
Early Phase 1 | |
Recruiting |
NCT05523167 -
A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.
|
Phase 2/Phase 3 | |
Recruiting |
NCT03324152 -
Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis
|
N/A | |
Completed |
NCT02043548 -
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
|
Phase 2 | |
Completed |
NCT03414086 -
Predictor of Clinical Response to Acthar in Myositis
|
||
Completed |
NCT04628936 -
Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.
|
Phase 2 | |
Completed |
NCT00213629 -
myoARRAY and TcLandscape Analysis for the Diagnosis of Inflammatory Myopathies
|
N/A | |
Completed |
NCT02971683 -
Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
|
Phase 3 | |
Active, not recruiting |
NCT00651040 -
Combined Treatment of Methotrexate + Glucocorticoids Versus Glucocorticoids Alone in Patients With Polymyositis and Dermatomyositis
|
Phase 3 | |
Completed |
NCT00138983 -
Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.
|
Phase 3 | |
Completed |
NCT00001331 -
Genetic and Family Studies of Inherited Muscle Diseases
|
N/A | |
Completed |
NCT00001261 -
Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies
|
Phase 2 | |
Completed |
NCT01415219 -
Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis
|
Phase 2 |